Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACARBAZINE vs DALTEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACARBAZINE vs DALTEPARIN: Safety Overview

Metric DACARBAZINE DALTEPARIN
Total FAERS Reports 5,105 3,570
Deaths Reported 847 789
Death Rate 16.6% 22.1%
Hospitalizations 1,914 1,443
Average Patient Age 45.5 yrs 67.7 yrs
% Female Patients 47.8% 39.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 4, 2002
Manufacturer Fresenius Kabi USA, LLC Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Discontinued Prescription